- Cocoon Bioscience has closed a €15 million ($15.9 million) round to grow its high-value proteins business, which includes developing recombinant proteins for cultivated meat growth media.
- The company will use the new funds to scale its business and build out its forthcoming production facilities in Spain.
- Columbus Venture Partners and Cleon Capital led the round with participation from Viscofan, North South Ventures and others.
![Cocoon Bioscience has recently acquired $16 million in funding to transform moths into bioreactors for the production of cultivated meat Cocoon Bioscience](https://gfi.org/wp-content/uploads/2021/02/Meat-chicken-bites-two-on-slate.jpg)
** Click here to read the full-text **